Comparison between Beta Drugs IPO and Shree Ganesh Remedies IPO.
IPO Details
Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while Shree Ganesh Remedies IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the Shree Ganesh Remedies IPO is up to ₹8.10 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Shree Ganesh Remedies IPO is ₹36.00 per share.
IPO Timetable
Beta Drugs IPO opens on Sep 29, 2017, while Shree Ganesh Remedies IPO opens on Sep 28, 2017. The closing date of Beta Drugs IPO and Shree Ganesh Remedies IPO is Oct 04, 2017, and Oct 05, 2017, respectively.
| | Beta Drugs IPO | Shree Ganesh Remedies IPO |
|---|
| Issue Open | Sep 29, 2017 | Sep 28, 2017 |
| Issue Close | Oct 04, 2017 | Oct 05, 2017 |
| Basis Of Allotment (Tentative) | Oct 10, 2017 | Oct 10, 2017 |
| Initiation of Refunds (Tentative) | | Oct 11, 2017 |
| Credit of Share (Tentative) | | Oct 12, 2017 |
| Listing date (Tentative) | Oct 12, 2017 | Oct 13, 2017 |
Financials & KPIs
Beta Drugs IPO P/E ratio is , as compared to Shree Ganesh Remedies IPO P/E ratio of .
Shares Offered
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in Shree Ganesh Remedies IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in Shree Ganesh Remedies IPO.
| | Beta Drugs IPO | Shree Ganesh Remedies IPO |
|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,29,600 shares | 1,26,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 10,83,200 shares | 11,25,000 shares |
| RII | 10,83,200 shares | 11,25,000 shares |
| Employee | 0 shares | 0 shares |
| Total | 21,66,400 shares | 22,50,000 shares |
Bids Received (Subscription)
Beta Drugs IPO subscribed 18.97x in total, whereas Shree Ganesh Remedies IPO subscribed 1.77x.
